Hormonal regulation of lactate dehydrogenase-A through activation of protein kinase C pathways in MCF-7 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 320, Issue 3, 2004, Pages 625-634

  Li, Xiangrong ^a   Qin, Chunhua ^a   Burghardt, Robert ^b   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Estrogen; Lactate dehydrogenase A; Non genomic; PKC activation

Indexed keywords

CELL EXTRACT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE DELETION; GENE MUTATION; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN MOTIF; TRANSACTIVATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; RATS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS);

MINK CELL FOCUS-FORMING VIRUS; RODENTIA;

EID: 3042807958     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.205     Document Type: Article

References (73)

1. Goldberg E. Lactic and malic dehydrogenases in human spermatozoa. Science. 139:1963;602-603
2. Richards A.H., Hilf R. Influence of pregnancy, lactation and involution on glucose-6-phosphate dehydrogenase and lactate dehydrogenase in the rat mammary gland. Endocrinology. 91:1972;287-295
3. Richards A.H., Hilf R. Effect of estrogen administration on glucose 6-phosphate dehydrogenase and lactate dehydrogenase isoenzymes in rodent mammary tumors and normal mammary glands. Cancer Res. 32:1972;611-616
4. Hilf R., Rector W.D., Orlando R.A. Multiple molecular forms of lactate dehydrogenase and glucose 6-phosphate dehydrogenase in normal and abnormal human breast tissues. Cancer. 37:1976;1825-1830
5. McCord J.M. Iron, free radicals, and oxidative injury. Semin. Hematol. 35:1998;5-12
6. Balinsky D., Platz C.E., Lewis J.W. Isozyme patterns of normal, benign, and malignant human breast tissues. Cancer Res. 43:1983;5895-5901
7. Nagai M.A., Sonohara S., Brentani M.M. Estrogen control of lactate dehydrogenase isoenzyme-5 in human breast cancer. Int. J. Cancer. 41:1988;10-16
8. Thomas M., Monet J.D., Brami M., Dautigny N., Assailly J., Ulmann A., Bader C.A. Comparative effects of 17β-estradiol, progestin R5020, tamoxifen and RU38486 on lactate dehydrogenase activity in MCF-7 human breast cancer cells. J. Steroid Biochem. 32:1989;271-277
9. 2′ -dibutyryl cyclic AMP increase the levels of lactate dehydrogenase-5 isozyme and its messenger RNA in rat C6 glioma cells J. Biol. Chem. 255:1980;11112-11121
10. 2′ -dibutyryl cyclic amp increase the rate of transcription and change the stability of lactate dehydrogenase a subunit messenger RNA in rat C6 glioma cells J. Biol. Chem. 258:1983;5312-5318
11. Short S., Short M.L., Milkowski D.M., Jungmann R.A. Functional analysis of cis- and trans-regulatory elements of the lactate dehydrogenase A subunit promoter by in vitro transcription. J. Biol. Chem. 266:1991;22164-22172
12. Short M.L., Huang D., Milkowski D.M., Short S., Kunstman K., Soong C.J., Chung K.C., Jungmann R.A. Analysis of the rat lactate dehydrogenase A subunit gene promoter/regulatory region. Biochem. J. 304:1994;391-398
13. Huang D., Jungmann R.A. Transcriptional regulation of the lactate dehydrogenase A subunit gene by the phorbol ester 12-. O -tetradecanoylphorbol- 13-acetate Mol. Cell Endocrinol. 108:1995;87-94
14. Huang D., Hubbard C.J., Jungmann R.A. Lactate dehydrogenase A subunit messenger RNA stability is synergistically regulated via the protein kinase A and C signal transduction pathways. Mol. Endocrinol. 9:1995;994-1004
15. Chung K.C., Huang D., Chen Y., Short S., Short M.L., Zhang Z., Jungmann R.A. Identification of a silencer module which selectively represses cyclic AMP-responsive element-dependent gene expression. Mol. Cell. Biol. 15:1995;6139-6149
16. Jungmann R.A., Huang D., Tian D. Regulation of LDH-A gene expression by transcriptional and posttranscriptional signal transduction mechanisms. J. Exp. Zool. 282:1998;188-195
17. Short S., Tian D., Short M.L., Jungmann R.A. Structural determinants for post-transcriptional stabilization of lactate dehydrogenase A mRNA by the protein kinase C signal pathway. J. Biol. Chem. 275:2000;12963-12969
18. Fukasawa K.M., Li S.S. Nucleotide sequence of the putative regulatory region of mouse lactate dehydrogenase-A gene. Biochem. J. 235:1986;435-439
19. Takano T., Li S.S.L. Sequence comparison of the promoter-regulatory region between human and mouse lactate dehydrogenase-A genes. J. Genet. Mol. Biol. 1:1990;34-44
20. Levin E.R. Cellular functions of plasma membrane estrogen receptors. Steroids. 67:2002;471-475
21. Watson C.S., Campbell C.H., Gametchu B. The dynamic and elusive membrane estrogen receptor-α Steroids. 67:2002;429-437
22. Kelly M.J., Wagner E.J. Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol. Metab. 10:1999;369-374
23. Levin E.R. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10:1999;374-377
24. Watson C.S., Gametchu B., Norfleet A.M., Campbel C.H., Thomas M.L. Rapid, nongenomic actions of estrogens. Women Cancer. 1:1998;21-28
25. Stoner M., Wang F., Wormke M., Nguyen T., Samudio I., Vyhlidal C., Marme D., Finkenzeller G., Safe S. Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor α and Sp3 proteins. J. Biol. Chem. 275:2000;22769-22779
26. Savouret J.F., Bailly A., Misrahi M., Rarch C., Redeuilh G., Chauchereau A., Milgrom E. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J. 10:1991;1875-1883
27. Dubik D., Shiu R.P.C. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263:1988;12705-12708
28. Berry M., Nunez A.-M., Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA. 86:1989;1218-1222
29. Weisz A., Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 18:1990;5097-5106
30. Zacharewski T.R., Bondy K.L., McDonell P., Wu Z.F. Antiestrogenic effects of 2, 3, 7, 8-tetrachlorodibenzo-. p -dioxin on 17β-estradiol-induced pS2 expression Cancer Res. 54:1994;2707-2713
31. Sathya G., Li W., Klinge C.M., Anolik J.H., Hilf R., Bambara R.A. Effects of multiple estrogen responsive elements, their spacing and location on estrogen response of reporter genes. Mol. Endocrinol. 11:1997;1994-2003
32. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510
33. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:1995;443-456
34. Wang F., Hoivik D., Pollenz R., Safe S. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes. Nucleic Acids Res. 26:1998;3044-3052
35. Sun G., Porter W., Safe S. Estrogen-induced retinoic acid receptor α1 gene expression: role of estrogen receptor-Sp1 complex. Mol. Endocrinol. 12:1998;882-890
36. Xie W., Duan R., Safe S. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Endocrinology. 140:1999;219-227
37. Xie W., Duan R., Chen I., Samudio I., Safe S. Transcriptional activation of thymidylate synthase by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology. 141:2000;2439-2449
38. Wang W., Dong L., Saville B., Safe S. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol. Endocrinol. 13:1999;1373-1387
39. Samudio I., Vyhlidal C., Wang F., Stoner M., Chen I., Kladde M., Barhoumi R., Burghardt R., Safe S. Transcriptional activation of DNA polymerase α gene expression in MCF-7 cells by 17β-estradiol. Endocrinology. 142:2001;1000-1008
40. Qin C., Singh P., Safe S. Transcriptional activation of insulin-like growth factor binding protein 4 by 17β-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology. 140:1999;2501-2508
41. Porter W., Saville B., Hoivik D., Safe S. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11:1997;1569-1580
42. Krishnan V., Wang X., Safe S. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 269:1994;15912-15917
43. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., Kladde M., Vyhlidal C., Safe S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J. Biol. Chem. 174:1999;32099-32107
44. Duan R., Porter W., Safe S. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology. 139:1998;1981-1990
45. Duan R., Xie W., Burghardt R., Safe S. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J. Biol. Chem. 276:2001;11590-11598
46. Duan R., Xie W., Li X., McDougal A., Safe S. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 294:2002;384-394
47. Firth J.D., Ebert B.L., Ratcliffe P.J. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270:1995;21021-21027
48. Swanson D.J., Zellmer E., Lewis E.J. The homeodomain protein Arix interacts synergistically with cyclic AMP to regulate expression of neurotransmitter biosynthetic genes. J. Biol. Chem. 272:1997;27382-27392
49. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300
50. Cho H.S., Katzenellenbogen B.S. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7:1993;441-452
51. Migliaccio A., Pagano M., Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene. 8:1993;2183-2191
52. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA. 91:1994;8517-8521
53. Sun M., Paciga J.E., Feldman R.I., Yuan Z.-Q., Coppola D., Lu Y.Y., Shelley S.A., Nicosia S.V., Cheng J.Q. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res. 61:2001;5985-5991
54. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14:2000;1649-1660
55. Biswas D.K., Reddy P.V., Pickard M., Makkad B., Pettit N., Pardee A.B. Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter. J. Biol. Chem. 273:1998;33817-33824
56. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18:1999;2500-2510
57. Improta-Brears T., Whorton A.R., Codazzi F., York J.D., Meyer T., McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA. 96:1999;4686-4691
58. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol. Endocrinol. 16:2002;116-127
59. Zhang Z., Maier B., Santen R.J., Song R.X. Membrane association of estrogen receptor α mediates estrogen effect on MAPK activation. Biochem. Biophys. Res. Commun. 294:2002;926-933
60. Razandi M., Oh P., Pedram A., Schnitzer J., Levin E.R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16:2002;100-115
61. Filardo E.J., Quinn J.A., Frackelton A.R.J., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 16:2002;70-84
62. Keshamouni V.G., Mattingly R.R., Reddy K.B. Mechanism of 17-β-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 and PKC-δ J. Biol. Chem. 277:2002;22558-22565
63. Razandi M., Pedram A., Greene G.L., Levin E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13:1999;307-319
64. Wang F., Samudio I., Safe S. Transcriptional activation of cathepsin D gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Cell. Endocrinol. 172:2001;91-103
65. Xing W., Archer T.K. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol. Endocrinol. 12:1998;1310-1321
66. Castro-Rivera E., Samudio I., Safe S. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 276:2001;30853-30861
67. Nakhla A.M., Khan M.S., Romas N.P., Rosner W. Estradiol causes the rapid accumulation of cAMP in human prostate. Proc. Natl. Acad. Sci. USA. 91:1994;5402-5405
68. Lazennec G., Thomas J.A., Katzenellenbogen B.S. Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J. Steroid Biochem. Mol. Biol. 77:2001;193-203
69. ′ -monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway Endocrinology. 144:2003;832-838
70. Sylvia V.L., Walton J., Lopez D., Dean D.D., Boyan B.D., Schwartz Z. 17β-Estradiol-BSA conjugates and 17β-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J. Cell. Biochem. 81:2001;413-429
71. Ansonoff M.A., Etgen A.M. Estradiol elevates protein kinase C catalytic activity in the preoptic area of female rats. Endocrinology. 139:1998;3050-3056
72. Marino M., Distefano E., Caporali S., Ceracchi G., Pallottini V., Trentalance A. β-Estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J. Cell. Physiol. 188:2001;170-177
73. Boyan B.D., Sylvia V.L., Frambach T., Lohmann C.H., Dietl J., Dean D.D., Schwartz Z. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen. Endocrinology. 144:2003;1812-1824